Your browser doesn't support javascript.
loading
AKR1C3 Promotes AR-V7 Protein Stabilization and Confers Resistance to AR-Targeted Therapies in Advanced Prostate Cancer.
Liu, Chengfei; Yang, Joy C; Armstrong, Cameron M; Lou, Wei; Liu, Liangren; Qiu, Xiaomin; Zou, Binhao; Lombard, Alan P; D'Abronzo, Leandro S; Evans, Christopher P; Gao, Allen C.
Afiliação
  • Liu C; Department of Urologic Surgery, University of California, Davis, Davis, California.
  • Yang JC; Department of Urologic Surgery, University of California, Davis, Davis, California.
  • Armstrong CM; Department of Urologic Surgery, University of California, Davis, Davis, California.
  • Lou W; Department of Urologic Surgery, University of California, Davis, Davis, California.
  • Liu L; Department of Urologic Surgery, University of California, Davis, Davis, California.
  • Qiu X; Department of Urologic Surgery, University of California, Davis, Davis, California.
  • Zou B; Department of Urologic Surgery, University of California, Davis, Davis, California.
  • Lombard AP; Department of Urologic Surgery, University of California, Davis, Davis, California.
  • D'Abronzo LS; Department of Urologic Surgery, University of California, Davis, Davis, California.
  • Evans CP; Department of Urologic Surgery, University of California, Davis, Davis, California.
  • Gao AC; UC Davis Comprehensive Cancer Center, University of California, Davis, Davis, California.
Mol Cancer Ther ; 18(10): 1875-1886, 2019 10.
Article em En | MEDLINE | ID: mdl-31308078
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Receptores Androgênicos / Processamento Alternativo / Resistencia a Medicamentos Antineoplásicos / Terapia de Alvo Molecular / Membro C3 da Família 1 de alfa-Ceto Redutase Limite: Animals / Humans / Male Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Receptores Androgênicos / Processamento Alternativo / Resistencia a Medicamentos Antineoplásicos / Terapia de Alvo Molecular / Membro C3 da Família 1 de alfa-Ceto Redutase Limite: Animals / Humans / Male Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2019 Tipo de documento: Article